Association of Insulin Glargine Treatment with Bone Mineral Density in Patients with Type 2 Diabetes Mellitus

Código QR

Association of Insulin Glargine Treatment with Bone Mineral Density in Patients with Type 2 Diabetes Mellitus

Dan Liu,1 Jing-Jie Bai,2 Jun-Jie Yao,1 Yong-Bo Wang,1 Tong Chen,1 Qian Xing,1 Ran Bai1 1Department of Endocrinology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, People’s Republic of China; 2Department of Endocrinology, Dalian Children’s Hospital, Dal...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Liu D, Bai JJ, Yao JJ, Wang YB, Chen T, Xing Q, Bai R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	type 2 diabetes mellitus insulin glargine osteoporosis bone mineral density Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/7b7924b7e01445ee8fbe887c3c0c385f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
por: Lau IT, et al.
Publicado: (2017)

rDNA insulin glargine U300 – a critical appraisal
por: Wang F, et al.
Publicado: (2016)

Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland
por: Thomann R, et al.
Publicado: (2020)

Effect of Adding Insulin Glargine on Glycemic Control in Critically Ill Patients Admitted to Intensive Care Units: A Prospective Randomized Controlled Study
por: Nader ND, et al.
Publicado: (2020)

Relationship Between Sclerostin (SOST) Expression and Genetic Loci rs851056, rs1230399 Polymorphisms and Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes in Xinjiang
por: Li J, et al.
Publicado: (2021)

On the safety of insulin Glargine
por: Ivan Ivanovich Dedov, et al.
Publicado: (2009)

The state of bone mineral density in the prolapse of the pelvic organs
por: Il’nur I. Musin, et al.
Publicado: (2021)

Effects of Laparoscopic Sleeve Gastrectomy on Bone Mineral Density and Bone Metabolism in Chinese Patients with Obesity
por: Chen X, et al.
Publicado: (2020)

Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis
por: Masashi Uehara, et al.
Publicado: (2021)

Enzyme-Linked Immunosorbent Assay Method Application in the Study of Comparative Pharmacokinetics of Insulin Glargin Preparations
por: L. N. Shitov, et al.
Publicado: (2019)

Type 1 Diabetes and Bone Fragility: Links and Risks
por: Starup-Linde J, et al.
Publicado: (2019)

Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study
por: Lu C, et al.
Publicado: (2017)

Relationship of Two-Hour Plasma Glucose and Abdominal Visceral Fat with Bone Mineral Density and Bone Mineral Content in Women with Different Glucose Metabolism Status
por: Jia X, et al.
Publicado: (2020)

Association Analysis of Insulin Resistance and Osteoporosis Risk in Chinese Patients with T2DM
por: Wang X, et al.
Publicado: (2021)

Lactobacillus helveticus (ATCC 27558) upregulates Runx2 and Bmp2 and modulates bone mineral density in ovariectomy-induced bone loss rats
por: Parvaneh M, et al.
Publicado: (2018)

Association Between HDL-C and Bone Mineral Density: An Cross-Sectional Analysis
por: Niu P, et al.
Publicado: (2021)

Insulin glargine does not increase the risk of malignancy.Synopsis of the article ?Combined randomised controlled trial experience of malignancies in studies using insulin glargine?byHome P.D. & Lagarenne P. (Diabetologia 2009, vol. 52 (12): 2499-2506)
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2010)

Validation of three tools for identifying painful new osteoporotic vertebral fractures in older Chinese men: bone mineral density, Osteoporosis Self-Assessment Tool for Asians, and fracture risk assessment tool
por: Lin JS, et al.
Publicado: (2016)

Sleep onset latency is related with reduced bone mineral density in elderly people with insomnia: a retrospective study
por: Tong Q, et al.
Publicado: (2018)

Consensus gene modules related to levels of bone mineral density (BMD) among smokers and nonsmokers
por: Bingyuan Lin, et al.
Publicado: (2021)

Gut microbiota is associated with bone mineral density: an observational and genome-wide environmental interaction analysis in the UK Biobank cohort
por: Bolun Cheng, et al.
Publicado: (2021)

The relationships between bone turnover markers and bone mineral density in postmenopausal type 2 diabetic women
por: Vadim V. Klimontov, et al.
Publicado: (2016)

Muscular strength measurements indicate bone mineral density loss in postmenopausal women
por: Zhou Z, et al.
Publicado: (2013)

Low TSH Levels Within Euthyroid Range Could Play a Negative Role on Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes
por: Liu C, et al.
Publicado: (2021)

POSITIVE IMPACT OF FREQUENT MILK AND DAIRY PRODUCTS CONSUMPTION ON BONE MINERAL DENSITY OF OVER 50-AGED MACEDONIAN WOMEN
por: Zora UZUNOSKA, et al.
Publicado: (2018)

A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose
por: Kress S, et al.
Publicado: (2021)

Specific higher levels of serum uric acid might have a protective effect on bone mineral density within a Chinese population over 60 years old: a cross-sectional study from northeast China
por: Chen F, et al.
Publicado: (2019)

Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014)

Associations of polymorphisms in the gene promoters of cytokines and matrix metalloproteinases with bone mineral density in postmenopausal type 2 diabetic women
por: Olga N. Fazullina, et al.
Publicado: (2018)

Relationship between nonalcoholic fatty liver disease and bone mineral density in adolescents with obesity: a meta-analysis
por: Sun Y, et al.
Publicado: (2019)

Relationship between abnormal glucose metabolism and osteoporosis in Han Chinese men over the age of 50 years
por: Liu M, et al.
Publicado: (2019)

Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes
por: Tarigan TJE, et al.
Publicado: (2021)

Regulatory SNP of RREB1 is Associated With Bone Mineral Density in Chinese Postmenopausal Osteoporosis Patients
por: Shuo Feng, et al.
Publicado: (2021)

Age-Related Changes in Body Composition and Bone Mineral Density and Their Relationship with the Duration of Diabetes and Glycaemic Control in Type 2 Diabetes
por: Tang Y, et al.
Publicado: (2020)

Bone Mineral Density Screening System Using CMOS-Sensor X-ray Detector
por: Areerat Maneerat, et al.
Publicado: (2021)

CHANGE OF INDICES OF MINERAL DENSITY OF BONE TISSUE AT CHRONIC TRAUMATIC OSTEOMYELITIS
por: S. N. Leonova
Publicado: (2014)

Treatment of osteoporosis with teriparatide: The Slovenian experience
por: Kocjan Tomaz, et al.
Publicado: (2021)

Osteoclasts May Affect Glucose Uptake-Related Insulin Resistance by Secreting Resistin
por: Li X, et al.
Publicado: (2021)

The relationship of total body composition with bone mineral density in postmenopausal women with type 2 diabetes
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2015)

Assessment risk of osteoporosis in Chinese people: relationship among body mass index, serum lipid profiles, blood glucose, and bone mineral density
por: Cui RT, et al.
Publicado: (2016)